Life-threatening hypokalaemia and lactate accumulation after autointoxication with Stacker 2®, a 'powerful slimming agent'

British Journal of Clinical Pharmacology

Volumn 66, Issue 5, 2008, Pages 728-731

  De Wijkerslooth, L R H ^a   Koch, B C P ^a   Malingre M M ^a   Smits, P ^b   Bartelink, A K M ^a  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CAFFEINE; EPHEDRA EXTRACT; LACTIC ACID; POTASSIUM; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; SODIUM POTASSIUM PHOSPHATE; STACKER 2; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIET SUPPLEMENTATION; DRUG INTOXICATION; ELECTROCARDIOGRAPHY; EPHEDRA; FEMALE; HUMAN; HYPOKALEMIA; LABORATORY TEST; LACTATE BLOOD LEVEL; LETTER; PHYSICAL EXAMINATION; POLYURIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SINUS TACHYCARDIA; ST SEGMENT DEPRESSION; SUICIDE ATTEMPT;

ADULT; ANTI-OBESITY AGENTS; CAFFEINE; FEMALE; HUMANS; HYPOKALEMIA; LACTIC ACID; NONPRESCRIPTION DRUGS; YOUNG ADULT;

EID: 55149123170     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03279.x     Document Type: Letter

References (14)

1. van Riel AJHP, de Vries I, Meulenbelt J. Gezondheidsrisico's door Ephedra in voedingssupplementen. Ned Tijdschr Geneeskd 2003 147 : 2017 9.
2. Marchei E, Pellegrini M, Pacifici R, Zuccaro P, Pichini S. A rapid and simple procedure for the determination of ephedrine alkaloids in dietary supplements by gas chromatography-mass spectrometry. J Pharm Biomed Anal 2006 41 : 1633 41.
3. Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW, Powell LW. Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 1990 47 : 516 24.
4. Mandel HG. Update on caffeine consumption, disposition and action. Food Chem Toxicol 2002 40 : 1231 4.
5. Alazami M, Lin SH, Cheng CJ, Davids MR, Halperin ML. Unusual causes of hypokalaemia and paralysis. Q J Med 2006 99 : 181 92.
6. Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci 2004 61 : 857 72.
7. Undem BJ. Pharmacotherapy of asthma. In : Goodman & Gilman's the Pharmacological Basis of Therapeutics, 11th edn, eds Brunton LL, Lazo JS, Parker KL. New York : McGraw-Hill, 2005 727 30.
8. Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med 1990 41 : 277 88.
9. Shi D, Padgett WL, Daly JW. Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors. Cell Mol Neurobiol 2003 23 : 331 47.
10. Kerrigan S, Lindsey T. Fatal caffeine overdose: two case reports. Forensic Sci Int 2005 153 : 67 9.
11. Passmore AP, Kondowe GB, Johnston GD. Caffeine and hypokalemia. Ann Intern Med 1986 105 : 468.
12. Appel CC, Myles TD. Caffeine-induced hypokalemic paralysis in pregnancy. Obstet Gynecol 2001 97 : 805 7.
13. Gennari FJ. Hypokalemia. N Engl Med J 1998 339 : 451 8.
14. Mudge DW, Johnson DW. Coca-Cola and kangaroos. Lancet 2004 364 : 1190 1.